Your account is not claimed yet. You can sign up with ORCID to claim your account.

Paola Barboro

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Venues

Cancers

International journal of molecular sciences

The International journal of biological markers

Investigational new drugs

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro

Italy

Biologo ricercatore

Publications

Paola Barboro, Alessandra Rubagotti, Silvia Poddine, Federica Grillo, Luca Mastracci, Francesco Boccardo
The prognostic value of aspartate beta-hydroxylase in early breast cancer. The International journal of biological markers 37 (3) (2022)
Imene Ben Toumia, Marco Ponassi, Paola Barboro, Erika Iervasi, Gabriela Coronel Vargas, Barbara Banelli, Stefano Fiordoro, Leila Chekir Ghedira, Franz Heinrich Kohnke, Alberto Izzotti, Camillo Rosano
Two calix[4]pyrroles as potential therapeutics for castration-resistant prostate cancer. Investigational new drugs 40 (6) (2022)
Roberto Benelli, Delfina Costa, Luca Mastracci, Federica Grillo, Mark Jon Olsen, Paola Barboro, Alessandro Poggi, Nicoletta Ferrari
Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971. Cancers 12 (5) (2020)
Roberto Benelli, Delfina Costa, Luca Mastracci, Federica Grillo, Mark Jon Olsen, Paola Barboro, Alessandro Poggi, Nicoletta Ferrari
Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 12 (4) (2020)
Carlo Cattrini, Davide Soldato, Alessandra Rubagotti, Linda Zinoli, Elisa Zanardi, Paola Barboro, Carlo Messina, Elena Castro, David Olmos, Francesco Boccardo
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer. Cancers 12 (10) (2020)
Roberto Benelli, Paola Barboro, Delfina Costa, Simonetta Astigiano, Ottavia Barbieri, Matteo Capaia, Alessandro Poggi, Nicoletta Ferrari
Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer. International journal of molecular sciences 20 (23) (2019)
Carlo Cattrini, Alessandra Rubagotti, Linda Zinoli, Luigi Cerbone, Elisa Zanardi, Matteo Capaia, Paola Barboro, Francesco Boccardo
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients. Cancers 11 (9) (2019)
Matteo Capaia, Ilaria Granata, Mario Rosario Guarracino, Andrea Petretto, Elvira Inglese, Carlo Cattrini, Nicoletta Ferrari, Francesco Boccardo, Paola Barboro
A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer. International journal of molecular sciences 19 (7) (2018)
Nicoletta Ferrari, Ilaria Granata, Matteo Capaia, Marina Piccirillo, Mario Rosario Guarracino, Roberta Venè, Antonella Brizzolara, Andrea Petretto, Elvira Inglese, Martina Morini, Simonetta Astigiano, Adriana Agnese Amaro, Francesco Boccardo, Cecilia Balbi, Paola Barboro
Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer. Cell communication and signaling : CCS 15 (1) (2017)

Paola Barboro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paola Barboro